首页>
外国专利>
ORAL LIQUID FORMULATION HAVING IMPROVED STABILITY COMPRISING AMBROXOL AND LEVODROPROPIZINE
ORAL LIQUID FORMULATION HAVING IMPROVED STABILITY COMPRISING AMBROXOL AND LEVODROPROPIZINE
展开▼
机译:包含氨溴索和左旋丙嗪的口服液制剂提高了稳定性
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to an oral liquid preparation containing: ambroxol or a pharmaceutically acceptable salt thereof; levodropropizine or a pharmaceutically acceptable salt thereof; and sodium pyrosulfite. The oral liquid preparation of the present invention exhibits a high synergistic effect and patients drug compliance by combining ambroxol and levodropropizine, which have different medicinal action mechanisms, and exhibits excellent storage stability by using sodium pyrosulfite, and thus can be useful as a medicine for treating acute and chronic respiratory diseases without the change in the medicinal effect for a long time.
展开▼